Centripetal migration and prolonged retention of microglia promotes spinal cord injury repair

Jianan Ye1, Fangli Shan1, Xinzhong Xu1,2

  • 1Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.

PubMed
Abstract

Insights

Enhancing microglial migration and retention via CX3CL1 and M-CSF boosts spinal cord injury repair. This strategy optimizes wound healing and axonal regrowth, crucial for locomotor recovery after SCI.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Neonatal microglia are vital for spinal cord injury (SCI) repair, including wound healing and axonal regeneration.
  • Limited microglia migration to adult lesion centers hinders their therapeutic potential in SCI recovery.

Purpose of the Study:

  • To investigate methods for enhancing microglial migration and retention at SCI lesion sites.
  • To evaluate the impact of targeted chemokine and growth factor delivery on SCI outcomes.

Main Methods:

  • Developed a mouse model of SCI involving in situ injection of C-X3-C motif chemokine ligand 1 (CX3CL1) and macrophage colony-stimulating factor (M-CSF).
  • Assessed wound healing, axonal preservation/regrowth anatomically, and locomotor function recovery using kinematics analysis.
  • Utilized C-X3-C motif chemokine receptor 1 (CX3CR1)-deficient mice to confirm the mechanism of action.

Main Results:

  • Decreased CX3CL1 expression and perilesional distribution limit microglial centripetal migration in SCI.
  • CX3CL1 alone promoted migration but did not improve functional recovery.
  • Combined CX3CL1 and M-CSF enhanced microglial migration and retention, improved wound healing, axonal preservation/regrowth, and locomotor function, an effect dependent on CX3CR1 signaling and potentially involving spleen tyrosine kinase (SYK).

Conclusions:

  • Microglial location and abundance are critical for orchestrating spinal cord injury repair.
  • Centripetal microglial dynamics represent a promising therapeutic target for SCI interventions.